hat the company had false articles written and published in prestigious medical journals to downplay the drug's risks, said the report.Besides Baycol, Bayer may also wind up in legal hot water over another drug since pulled from the market (in 2007) called Trayslol, a drug used to limit bleeding in cardiac and other surgeries.